Drugs / Biotech / BioTech / Drug / Clinical / National blog main / San Francisco / San Francisco blog main / San Francisco top stories / Adynxx / Cubist Pharmaceuticals / deals / Domain Associates / FDA / Food and Drug Administration / investing / Life Sciences / Merck / pain drugs / Rick Orr / TPG Biotech

Pain Drug Developer Adynxx Picks Up $16M for Another Clinical Trial

Posted on: Jan 11, 2017   |   Posted by: Biotech Mag

Pain Drug Developer Adynxx Picks Up $16M for Another Clinical Trial

Despite the wide range of pain relievers available, many patients find these drugs fall short of easing pain after surgery and during rehabilitation. Drug developer Adynxx is...

Continue reading ...